A number of studies have assessed the impact of adaptive immunity on disease progression in several early-onset AD (EOAD) transgenic (Tg) mouse models, which overexpress the Amyloid precursor protein (APP) and presenilin 1 (PS1) proteins. The gene discussed is APP; the disease is Alzheimer disease.